-->

Tag: Jazz Pharmaceuticals

Home / Jazz Pharmaceuticals

Categories

New dosing regimen for asparaginase erwinia chrysanthemi (recombinant) is approved by FDA

Dec 2022: A new Monday-Wednesday-Friday dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn has been approved by the Food and Drug Administration (Rylaze, Jazz Pharmaceuticals). P...
jazz-pharmaceuticals

FDA has approved asparaginase erwinia chrysanthemi (recombinant) for leukaemia and lymphoma

August 2021: The Food and Drug Administration has approved asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) as part of a multi-agent chemotherapeutic regimen ...
jazz-pharmaceuticals

Scan the code